These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 20212113)

  • 1. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
    Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
    Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
    Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity.
    Chiu YH; Lee JY; Cantley LC
    Mol Cell; 2014 Apr; 54(1):193-202. PubMed ID: 24657164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
    Brachmann SM; Yballe CM; Innocenti M; Deane JA; Fruman DA; Thomas SM; Cantley LC
    Mol Cell Biol; 2005 Apr; 25(7):2593-606. PubMed ID: 15767666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase.
    Luo J; Sobkiw CL; Logsdon NM; Watt JM; Signoretti S; O'Connell F; Shin E; Shim Y; Pao L; Neel BG; Depinho RA; Loda M; Cantley LC
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10238-43. PubMed ID: 16006513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
    Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.
    Taniguchi CM; Tran TT; Kondo T; Luo J; Ueki K; Cantley LC; Kahn CR
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12093-7. PubMed ID: 16880400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase.
    Rajala RV; McClellan ME; Chan MD; Tsiokas L; Anderson RE
    Biochemistry; 2004 May; 43(19):5637-50. PubMed ID: 15134438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex.
    Luo J; Field SJ; Lee JY; Engelman JA; Cantley LC
    J Cell Biol; 2005 Aug; 170(3):455-64. PubMed ID: 16043515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit.
    Ueki K; Algenstaedt P; Mauvais-Jarvis F; Kahn CR
    Mol Cell Biol; 2000 Nov; 20(21):8035-46. PubMed ID: 11027274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p85 Associates with unphosphorylated PTEN and the PTEN-associated complex.
    Rabinovsky R; Pochanard P; McNear C; Brachmann SM; Duke-Cohan JS; Garraway LA; Sellers WR
    Mol Cell Biol; 2009 Oct; 29(19):5377-88. PubMed ID: 19635806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
    Geering B; Cutillas PR; Vanhaesebroeck B
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):199-203. PubMed ID: 17371237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation.
    Cattley RT; Lee M; Boggess WC; Hawse WF
    J Biol Chem; 2020 Jun; 295(24):8236-8251. PubMed ID: 32358062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of p85α Alterations in Cancer.
    Marshall JDS; Whitecross DE; Mellor P; Anderson DH
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30650664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the PI3K pathway through a p85α monomer-homodimer equilibrium.
    Cheung LW; Walkiewicz KW; Besong TM; Guo H; Hawke DH; Arold ST; Mills GB
    Elife; 2015 Jul; 4():e06866. PubMed ID: 26222500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
    Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal domains of the class ia phosphoinositide 3-kinase regulatory subunit play a role in cytoskeletal but not mitogenic signaling.
    Hill KM; Huang Y; Yip SC; Yu J; Segall JE; Backer JM
    J Biol Chem; 2001 May; 276(19):16374-8. PubMed ID: 11278326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAT-protein blockade during ischemia/reperfusion reveals critical role for p85 PI3K-PTEN interaction in cardiomyocyte injury.
    Zhu X; Shao ZH; Li C; Li J; Zhong Q; Learoyd J; Meliton A; Meliton L; Leff AR; Vanden Hoek TL
    PLoS One; 2014; 9(4):e95622. PubMed ID: 24752319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
    Jiang BH; Jiang G; Zheng JZ; Lu Z; Hunter T; Vogt PK
    Cell Growth Differ; 2001 Jul; 12(7):363-9. PubMed ID: 11457733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.
    Mellor P; Marshall JDS; Ruan X; Whitecross DE; Ross RL; Knowles MA; Moore SA; Anderson DH
    Sci Rep; 2018 May; 8(1):7108. PubMed ID: 29740032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.